Seattle Infectious Disease Clinic
Hospital
Location:
Seattle,
United States (USA) (US)
Long-term follow-up of HIV-1-infected adults who received the F4/AS01(B) HIV-1 vaccine candidate in two randomised controlled trials (2018)
Harrer T, Dinges W, Roman F
Journal article
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial (2016)
Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, Garcia F, Harrer T, Lelievre JD, et al.
Journal article